Unexplained weight loss (UWL), a decrease in body weight without an identifiable cause, often presents a diagnostic challenge for clinicians. This phenomenon, which is often associated with underlying serious disease, necessitates a comprehensive approach for evaluation.
The first step in evaluating UWL should be a thorough history and physical examination. Clinicians should inquire about changes in appetite, dietary habits, and physical activity. It is also important to consider medications, psychosocial factors, and systemic symptoms such as fever, pain, or fatigue. Physical examination should focus on signs of malnutrition, malignancy, and endocrine or metabolic disorders.
Initial laboratory testing should include a complete blood count, metabolic panel, liver function tests, thyroid function tests, and urinalysis. Depending on the clinical suspicion, additional tests such as tumor markers, autoimmune panels, or imaging studies may be warranted.
In elderly patients, UWL may be the only sign of a serious underlying condition such as malignancy or depression. In such cases, a multidisciplinary approach involving geriatricians, psychiatrists, and dietitians may be beneficial. In patients with HIV or tuberculosis, UWL may indicate disease progression or suboptimal treatment response.
If initial evaluation does not reveal a cause, clinicians should monitor the patient's weight and symptoms. If weight loss continues or new symptoms develop, referral to a specialist may be necessary. Early referral can facilitate timely diagnosis and treatment, potentially improving patient outcomes.
UWL is a complex clinical presentation that warrants a comprehensive, stepwise approach. By combining a meticulous history and physical examination with targeted laboratory investigations, clinicians can effectively narrow down potential causes. In cases where the etiology remains elusive, ongoing monitoring and specialist referral can ensure optimal patient care.
1.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
2.
FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer
3.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
4.
AI-based liquid biopsy shows promise for detecting brain cancer
5.
The Kansas Cancer Center awarded two Indian American doctors professorships.
1.
Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers
2.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
3.
Examining Serum Osmolality: What It Is And How To Test For It
4.
Evolutionary Bottlenecks in Tumor Progression
5.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Thromboprophylaxis In Medical Settings
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation